Literature DB >> 29756493

Association between urinary sodium excretion and coronary heart disease in hospitalized elderly patients in China.

Chun-Lin Li1, Hai-Jun Wang1, Quan-Jin Si1, Jin Zhou1, Kai-Liang Li1, Yu Ding1.   

Abstract

Objective This study was performed to evaluate the association between urinary sodium excretion and coronary heart disease (CHD) in hospitalized elderly patients in China. Methods The 24-h urinary excretion specimens of 541 patients were collected, and the serum creatinine concentration and urinary sodium/potassium ratio were measured. Associations were explored by multivariate logistic regression analysis. Results The mean 24-h urinary sodium excretion was 200.4 mmol, corresponding to 11.7 g of salt intake. Both of these values were higher in men than in women. The salt intake of 80- to 89-year-old patients was significantly lower than that of 70- to 79-year-old patients. The 24-h urinary sodium excretion and spot urine Na/K ratios were significantly higher in overweight/obese and hypertensive patients. The 24-h urinary sodium excretion of men who smoked was significantly higher than that of women. The spot urine Na/K ratio was significantly higher in patients with cerebral thrombosis. The urinary Na/K ratio, smoking status, and hypertension were independent risk factors for CHD. Conclusions This cross-sectional survey suggests that the Na/K ratio may better represent salt loading than Na excretion alone in studying the association between sodium intake and CHD. There was no association between sodium and CHD prevalence.

Entities:  

Keywords:  Aged; coronary heart disease; dietary; sodium; sodium excretion; sodium/potassium ratio

Mesh:

Substances:

Year:  2018        PMID: 29756493      PMCID: PMC6134650          DOI: 10.1177/0300060518772222

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


Introduction

Globally, one of the main preventive measures against cardiovascular disease is to reduce sodium intake,[1] which is commonly achieved by a salt-restricted diet.[2] In most countries, high salt intake remains a serious public health problem; from a medical standpoint, the current recommendation for salt intake is 5 to 6 g/day. However, further limiting salt intake to 3 g/day exerts obvious adverse effects. More than half of the world’s population consumes 7.5 to 15.0 g/day of salt.[3] In China, the average salt intake is approximately 9 to 12 g/day.[4] Although salt intake has been extensively studied among people of a wide range of ages, the salt intake of older adults has seldom been reported. China is facing a serious aging problem characterized by rapid growth of the population of older people. The morbidity rate of coronary heart disease (CHD) among older adults is rapidly increasing.[5] The salt intake of most Chinese people evidently surpasses the recommended level.[6] Thus, a thorough understanding of the salt intake of high-risk populations is of great clinical significance. The aim of this study was to detect the sodium intake of Chinese older adults based on the 24-h urinary sodium excretion and evaluate the prevalence of CHD associated with salt intake.

Materials and methods

Patients

This cross-sectional survey was conducted in our hospital from June 2012 to July 2014. Patients aged ≥60 years who were able to independently walk indoors were selected. This study was approved by the ethics committee of our hospital, and written informed consent was obtained from all patients. All patients underwent biochemical and clinical examinations. Patients taking diuretic agents, those from whom we were unable to collect urine samples, and those with severe renal or hepatic impairment were excluded. The criterion for renal impairment was a serum creatinine level of ≥133 µmol/L. The criterion for hepatic impairment was an alanine transaminase level of >40 U/L.

Urine sampling protocols

Spot urine samples were collected to estimate the spot urine sodium/potassium (Na/K) ratio. Twenty-four-hour urine samples were also collected and analyzed to determine the urinary sodium excretion. The procedures were explained both orally and in written form. All samples were collected into provided bags. Urine from the same patient was completely mixed, and the volume was then measured. The urine (20 mL) was subsequently pooled and frozen at −20°C until biochemical analysis. The 24-h urinary sodium level was the mean of the results obtained on three consecutive days and expressed in units of mmol/24 h. The estimated salt intake was calculated according to the following formula: urinary sodium (mmol/L) × 24-h urine volume (L) × 58.5.[7] The blood creatinine level was determined using an automated enzymatic procedure.

Clinical and biochemical measurements

All patients’ blood pressures were measured by trained doctors. The patients rested in a seated position for at least 5 min before the measurements. Blood pressure was measured three consecutive times, and the mean was recorded. Information about patients’ recent medical histories, lifestyle habits, and medications were recorded. Hypertension was diagnosed in patients with a brachial diastolic blood pressure of ≥90 mmHg, brachial systolic blood pressure of ≥140 mmHg, and/or the use of antihypertensive medication. The patients’ peripheral venous blood specimens were taken after 8 h of overnight fasting. The total serum cholesterol concentration was determined by standardized automated methods. Diabetes mellitus was diagnosed in patients with a fasting blood glucose concentration of ≥7.0 mmol/L (126 mg/dL), a random blood glucose concentration of 11.1 mmol/L (200 mg/dL), or the use of anti-diabetic drugs.

Statistical analysis

Statistical analysis was performed by SPSS version 17.0 (SPSS, Inc., Chicago, IL, USA). A P value of <0.05 was considered statistically significant. Categorical variables were examined by the χ2 test. Continuous variables are expressed as mean ± standard deviation. Multivariate logistic regression analysis was conducted to assess the independent risk factors for CHD. Univariate logistic regression analysis was performed to select the factors associated with CHD, and variables with a P value of <0.25 were retained and evaluated.

Results

Patient characteristics by sex

Table 1 shows the baseline clinical data of the patients by sex. Of the 541 patients, 316 were men (58.4%) and 225 were women (41.6%). The mean age was 82.8 years, and the mean body mass index was 24.32 kg/m2. There were no significant differences in age and body mass index between men and women. However, the proportion of men with a history of smoking and drinking was higher than that of women (P < 0.05). In addition, men were significantly more prone to hypertension, CHD, and cerebral thrombosis and (P < 0.05). In contrast, women had a significantly higher prevalence of dyslipidemia than did men (P < 0.05). Men had significantly higher levels of urinary potassium and sodium than did women (P < 0.001).
Table 1.

Patients’ characteristics

Total(n = 541)Men(n = 316)Women(n = 225)
General condition
 Age, years82.8 ± 3.586.8 ± 4.280.9 ± 3.5
 BMI, kg/m224.32 ± 3.223.73 ± 2.025.30 ± 2.6
 Smoking9372*21
 Drinking211142*69
 SBP, mmHg133.7 ± 18.1132.3 ± 18.0134.5 ± 17.6
 DBP, mmHg78.7 ± 9.677.7 ± 8.979.6 ± 9.5
 Scr, µmol/L139.2 ± 19.5138.9 ± 19.3141.9 ± 20.5
Basic disease
 Hypertension366226*140
 CHD287175*112
 DM362201161
 Cerebral thrombosis209127*82
 Dyslipidemia275146129*
Medication use
 Aspirin402245157
 Clopidogrel238121117
 Statins364202162
 Beta blockers258154104
 Nitrates244132112
 ACEI/ARB248141107
 CCB297182115
Urinary measurements
 Urine volume, L2.8 ± 0.93.1 ± 0.32.6 ± 0.8
 Urine Na excretion, mmol/L193.4 ± 32.1213.6 ± 36.2**189.2 ± 39.8
 Urine K excretion, mmol/L23.8 ± 3.124.6 ± 4.5**21.7 ± 4.6

Data are presented as mean ± standard deviation or number of patients.

CHD, coronary heart disease; DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Scr, serum creatinine; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker.

*P < 0.05, men vs. women; **P < 0.001, men vs. women.

Patients’ characteristics Data are presented as mean ± standard deviation or number of patients. CHD, coronary heart disease; DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; Scr, serum creatinine; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker. *P < 0.05, men vs. women; **P < 0.001, men vs. women.

Urinary sodium and potassium excretion and creatinine clearance rates in different age groups

Table 2 lists the estimated daily salt intake and 24-h urinary sodium and potassium excretion of each age subgroup. The mean total 24-h urinary sodium excretion was 200.4 ± 19.1 mmol, corresponding to a mean salt intake of 11.7 ± 1.1 g. Men had a higher 24-h urinary sodium excretion and corresponding salt intake than women (P < 0.05). However, the creatinine clearance rate, 24-h urinary potassium level, and urinary Na/K ratio were similar between men and women. The urinary excretion levels of sodium and potassium and the creatinine clearance rate decreased with increasing age. The salt intake of patients aged 80 to 89 years was lower than that of patients aged 70 to 79 years (P < 0.05). The salt intake of men was significantly higher than that of women in the 70- to 79-year and >90-year subgroups (P < 0.05).
Table 2.

Urinary sodium and potassium excretion and creatinine clearance rate in different age groups

SexAge group, yearsnUrinary Na excretion (mmol/24 h)Urinary K excretion (mmol/24 h)Na/K ratioCCR (mL/min)Salt intake (g/d)
Men60–6975223.6 ± 18.270.1 ± 15.33.29 ± 1.56153.6 ± 20.113.1 ± 1.1
70–7994218.3 ± 19.168.0 ± 14.73.31 ± 1.33151.2 ± 19.812.7 ± 1.1
80–8996182.5 ± 20.757.3 ± 13.63.35 ± 1.26133.4 ± 18.610.6 ± 1.2
≥9051178.4 ± 17.847.6 ± 12.23.26 ± 1.80103.5 ± 20.510.4 ± 1.0
Subtotal316211.4 ± 19.560.6 ± 13.83.32 ± 1.72134.5 ± 20.512.4 ± 1.1
Women60–6977217.1 ± 19.368.2 ± 17.63.28 ± 2.06150.1 ± 24.012.7 ± 1.5
70–7953195.7 ± 22.465.6 ± 16.93.38 ± 1.83150.3 ± 21.211.4 ± 1.4
80–8965175.9 ± 23.260.3 ± 12.83.51 ± 1.41137.8 ± 23.410.3 ± 1.1
≥9030166.0 ± 19.945.9 ± 13.13.40 ± 1.21119.6 ± 18.79.7 ± 1.6
Subtotal225200.2 ± 17.659.5 ± 12.73.36 ± 1.81138.5 ± 20.511.7 ± 1.0
Total60–69152221.6 ± 31.168.3 ± 19.53.24 ± 1.93151.2 ± 26.912.9 ± 1.8
70–79147205.8 ± 27.766.2 ± 18.53.20 ± 1.71150.7 ± 21.812.0 ± 1.6
80–89161181.1 ± 19.858.9 ± 16.63.37 ± 1.62135.9 ± 19.510.6 ± 1.2
≥9081172.5 ± 18.247.7 ± 13.13.65 ± 1.80101.0 ± 19.910.1 ± 1.1
Subtotal541200.4 ± 19.159.6 ± 17.33.36 ± 1.91138.5 ± 20.511.7 ± 1.1

Data are presented as mean ± standard deviation.

Na/K ratio, sodium/potassium ratio; CCR, creatinine clearance rate.

Salt intake was estimated as follows: urinary sodium (mmol/L) × 24-h urine volume (L) × 58.5 g.

Urinary sodium and potassium excretion and creatinine clearance rate in different age groups Data are presented as mean ± standard deviation. Na/K ratio, sodium/potassium ratio; CCR, creatinine clearance rate. Salt intake was estimated as follows: urinary sodium (mmol/L) × 24-h urine volume (L) × 58.5 g.

Association of clinical factors with urinary sodium excretion and spot urine Na/K ratio

Table 3 shows the associations of clinical and lifestyle factors with urinary sodium excretion and the spot urine Na/K ratio. Men had higher 24-h urinary sodium excretion than women (P < 0.05). The 24-h urinary sodium excretion levels and spot urine Na/K ratios were significantly higher in patients who were obese or overweight or who had hypertension or coronary artery disease (P < 0.05). The 24-h urinary sodium excretion of men who smoked was higher than that of women (P < 0.05). In contrast, the spot urine Na/K ratio was higher in patients with cerebral thrombosis (P < 0.05). Men and women had similar spot urine Na/K ratios, and the 24-h urinary sodium excretions of patients with cerebral thrombosis (yes versus no) and dyslipidemia (yes versus no) were not significantly different.
Table 3.

Association of clinical factors with urinary sodium excretion and spot urine Na/K ratio

nUrinary sodium excretion (mmol/24 h)Spot urine Na/K ratio
Sex
 Men316211.4 ± 19.53.32 ± 1.72
 Women225200.2 ± 17.63.36 ± 1.81
P0.00010.7930
Obesity
 Normal weight (BMI < 24 kg/m2)223201.4 ± 19.53.25 ± 1.82
 Obese/overweight (BM ≥ 24 kg/m2)318223.2 ± 17.63.58 ± 1.81
P0.00010.0378
Drinking
 Yes211203.6 ± 16.03.32 ± 1.62
 No330200.8 ± 17.53.39 ± 1.73
P0.06120.6382
Smoking
 Yes93241.4 ± 15.53.42 ± 1.55
 No448210.2 ± 18.63.17 ± 1.49
P0.00010.14
Hypertension
 Yes366236.4 ± 18.53.62 ± 1.31
 No205215.2 ± 17.23.36 ± 1.25
P0.00010.0211
Coronary artery disease
 Yes287208.5 ± 16.33.56 ± 1.52
 No254205.6 ± 15.93.26 ± 1.39
P0.03720.0174
Type 2 diabetes
 Yes362221.2 ± 19.13.39 ± 1.22
 No179218.2 ± 16.63.34 ± 1.51
P0.07350.6793
Cerebral thrombosis
 Yes209208.1 ± 17.73.46 ± 1.26
 No332205.8 ± 15.83.16 ± 1.60
P0.11630.0219
Dyslipidemia
 Yes275210.9 ± 19.63.39 ± 1.62
 No266195.2 ± 17.33.21 ± 1.50
P0.05190.1809

Data are presented as mean ± standard deviation unless otherwise indicated.

Na/K ratio, sodium/potassium ratio; BMI, body mass index.

Association of clinical factors with urinary sodium excretion and spot urine Na/K ratio Data are presented as mean ± standard deviation unless otherwise indicated. Na/K ratio, sodium/potassium ratio; BMI, body mass index.

Multivariate logistic regression analysis

Multivariate logistic regression analysis was performed using the presence versus absence of CHD as the dependent variable. Age, smoking status, drinking status, the creatinine clearance rate, urinary sodium and potassium excretion, and the urinary Na/K ratio were included as independent variables (Table 4). An increased urinary Na/K ratio (odds ratio [OR], 1.20; 95% confidence interval [CI], 1.128–1.525; P = 0.008), smoking status (OR, 1.316; 95% CI, 1.103–1.359; P = 0.007), and hypertension (OR, 1.328; 95% CI, 1.101–1.412; P = 0.013) were independently associated with a higher risk of CHD.
Table 4.

Multivariate logistic regression analysis of relevant factors of coronary heart disease

VariableβSEWaldOR(95% CI) P
Age0.0150.0131.6810.936(0.910–1.005)0.090
BMI0.1230.0723.1171.135(0.908–1.013)0.105
Smoking0.0580.0304.5011.311(1.092–1.379)0.007
SBP0.1250.0263.5281.205(0.902–1.315)0.128
Na/K ratio0.1390.0636.2121.210(1.125–1.520)0.008
CCR0.0780.0711.1081.075(0.945–1.200)0.075
DM0.0520.0422.6181.041(0.980–1.127)0.099
Hypertension0.0120.0056.8321.321(1.111–1.422)0.013
Dyslipidemia0.0150.0253.5281.105(0.862–1.215)0.138

BMI, body mass index; CCR, creatinine clearance rate; Na/K ratio, urinary sodium/potassium ratio; DM, diabetes mellitus; SE, standard error; OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure.

Multivariate logistic regression analysis of relevant factors of coronary heart disease BMI, body mass index; CCR, creatinine clearance rate; Na/K ratio, urinary sodium/potassium ratio; DM, diabetes mellitus; SE, standard error; OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure.

Discussion

Measurement of 24-h urine sodium excretion has been considered a reliable method of salt intake estimation and has been performed in many epidemiologic and clinical studies.[8] However, salt intake has infrequently been estimated using 24-h urinary samples in China, and older adults have not been targeted. The present study has three main findings. First, most Chinese older adults consume a much higher salt level than that recommended by the World Health Organization (5 g/day).[9] The mean salt intake of men and women in the present study was 12.4 and 11.7 g/day, respectively. These levels are lower than those of other studies, most of which have shown a sodium intake of around 5.5 to 6.0 g/day. The urine volumes showed no indication of undercollection; thus, the findings likely reflect the diets of people as they age. Second, the salt intake and creatinine clearance rate gradually decreased with age. Third, a high urinary Na/K ratio was an independent risk factor for CHD. We are the first to investigate the salt intake of elderly adults in China. Our survey of salt intake showed that salt consumption among Chinese older adults markedly surpasses the recommended upper limit by the World Health Organization. In China, pickled foods and high soy sauce consumption contribute to this large salt intake.[10] The significantly greater salt intake by men than women can be explained by their different food habits and higher overall food intake. A recent study of Chinese postmenopausal women in Hong Kong showed that increased fruit intake and decreased sodium in soup is a valid strategy for reducing sodium loading.[11] High salt intake is well documented as a main risk factor for hypertension.[12] Some studies have indicated a positive association between the prevalence of cardiovascular disease and high sodium intake.[13] Cumulative evidence has shown that decreasing salt intake to <5 g/day can mitigate cardiovascular disease by >17% and the stroke incidence by >23%.[14] He and MacGregor[15] suggested that even a minor salt reduction of 2.3 g/day could reduce the prevalence of cardiovascular disease onset by 20%. Our results indicate that the urinary Na/K ratio is an independent risk factor for CHD, which may be explained by several mechanisms. First, kidney function declines with age, especially in elderly patients.[16] Older adults have about a 20% decrease in the maximum urinary osmolality compared with younger patients.[17] Likewise, in the present study, the creatinine level and urinary sodium excretion decreased as age increased. Thus, compared with sodium excretion, the urinary Na/K ratio better reflects the association between sodium and CHD. Second, potassium and sodium in the diet could reflect the coordination of nutrients because high levels are closely associated with increased prevalences of cardiovascular disease and adverse events.[18] The detrimental effects of high salt intake can be relieved by dietary supplementation of potassium.[19] Alimentary control and dietary diversification are features of individuals at lower risk of developing CHD.[20] However, our study still has several limitations. First, because the patients’ diseases were determined with a self-reported questionnaire, the identification may not have been accurate. Second, urine samples were collected in 24 h, so dilution bias may have been present due to individual variations within 1 day. Third, this cross-sectional study failed to explore the causal association between sodium intake and CHD. Regardless, further studies are ongoing in our group. Elderly Chinese adults in the present study had much higher salt intake than the currently recommended level (6 g/day). Several factors may affect the association between CHD and sodium intake. There was no association between sodium and CHD prevalence. Furthermore, measurement of the Na/K ratio may better represent salt loading than measurement of Na excretion alone.
  17 in total

Review 1.  Water homeostasis and ageing.

Authors:  P A O'Neill; K A McLean
Journal:  Med Lab Sci       Date:  1992-12

2.  Experimental epidemiology of chronic sodium chloride toxicity and the protective effect of potassium chloride.

Authors:  G R MENEELY; C O BALL
Journal:  Am J Med       Date:  1958-11       Impact factor: 4.965

3.  The influence of age on the renal response to water deprivation in man.

Authors:  J W Rowe; N W Shock; R A DeFronzo
Journal:  Nephron       Date:  1976       Impact factor: 2.847

4.  Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials.

Authors:  Feng J He; Graham A MacGregor
Journal:  Lancet       Date:  2011-07-30       Impact factor: 79.321

5.  Ethnic and environmental differences in various markers of dietary intake and blood pressure among Chinese Han and three other minority peoples of China: results from the WHO Cardiovascular Diseases and Alimentary Comparison (CARDIAC) Study.

Authors:  L Liu; L Liu; Y Ding; Z Huang; B He; S Sun; G Zhao; H Zhang; T Miki; S Mizushima; K Ikeda; Y Nara; Y Yamori
Journal:  Hypertens Res       Date:  2001-05       Impact factor: 3.872

Review 6.  Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases.

Authors:  Pierre Meneton; Xavier Jeunemaitre; Hugh E de Wardener; Graham A MacGregor
Journal:  Physiol Rev       Date:  2005-04       Impact factor: 37.312

7.  Priority actions for the non-communicable disease crisis.

Authors:  Robert Beaglehole; Ruth Bonita; Richard Horton; Cary Adams; George Alleyne; Perviz Asaria; Vanessa Baugh; Henk Bekedam; Nils Billo; Sally Casswell; Michele Cecchini; Ruth Colagiuri; Stephen Colagiuri; Tea Collins; Shah Ebrahim; Michael Engelgau; Gauden Galea; Thomas Gaziano; Robert Geneau; Andy Haines; James Hospedales; Prabhat Jha; Ann Keeling; Stephen Leeder; Paul Lincoln; Martin McKee; Judith Mackay; Roger Magnusson; Rob Moodie; Modi Mwatsama; Sania Nishtar; Bo Norrving; David Patterson; Peter Piot; Johanna Ralston; Manju Rani; K Srinath Reddy; Franco Sassi; Nick Sheron; David Stuckler; Il Suh; Julie Torode; Cherian Varghese; Judith Watt
Journal:  Lancet       Date:  2011-04-05       Impact factor: 79.321

8.  Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study.

Authors:  Nancy R Cook; Eva Obarzanek; Jeffrey A Cutler; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  Arch Intern Med       Date:  2009-01-12

9.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).

Authors:  Nancy R Cook; Jeffrey A Cutler; Eva Obarzanek; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  BMJ       Date:  2007-04-20

10.  Quantifying options for reducing coronary heart disease mortality by 2020.

Authors:  Mark D Huffman; Donald M Lloyd-Jones; Hongyan Ning; Darwin R Labarthe; Maria Guzman Castillo; Martin O'Flaherty; Earl S Ford; Simon Capewell
Journal:  Circulation       Date:  2013-05-09       Impact factor: 29.690

View more
  5 in total

1.  Dietary Sodium Intake and Health Indicators: A Systematic Review of Published Literature between January 2015 and December 2019.

Authors:  Katherine J Overwyk; Zerleen S Quader; Joyce Maalouf; Marlana Bates; Jacqui Webster; Mary G George; Robert K Merritt; Mary E Cogswell
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

2.  Study on the correlation between Left Ventricular Hypertrophy and Coronary Artery disease in the very elderly patients with hypertension.

Authors:  Jian-Hua Sun; Xiao-Kun Liu; Qi Zhang; Qing-Hua Zhang
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

3.  Science of Salt: A regularly updated systematic review of salt and health outcomes studies (April to October 2018).

Authors:  Rachael M McLean; Kristina S Petersen; JoAnne Arcand; Daniela Malta; Sarah Rae; Sudhir Raj Thout; Kathy Trieu; Claire Johnson; Norman R C Campbell
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-06-27       Impact factor: 3.738

4.  Application Effect of Meticulous Nursing on Community Elderly Patients with Coronary Heart Disease under the Background of Medical Treatment Partnerships.

Authors:  Wei Hao; Tian Ma; Chun Feng
Journal:  J Healthc Eng       Date:  2021-12-11       Impact factor: 2.682

5.  Transcriptome Sequencing to Detect the Potential Role of Long Noncoding RNAs in Salt-Sensitive Hypertensive Rats.

Authors:  Hao Wu; Sibo Zhu; Rui Yuan; Yang Yi; Hanqing Wang; Bo Gu; Timing Zhen; Kaichen Xing; Jun Ma
Journal:  Biomed Res Int       Date:  2019-12-06       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.